These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 30257344)
1. Volatile anesthetics sevoflurane targets leukemia stem/progenitor cells via Wnt/β-catenin inhibition. Ruan X; Jiang W; Cheng P; Huang L; Li X; He Y; Mai M; Tan Z Biomed Pharmacother; 2018 Nov; 107():1294-1301. PubMed ID: 30257344 [TBL] [Abstract][Full Text] [Related]
2. Amide-linked local anesthetics preferentially target leukemia stem cell through inhibition of Wnt/β-catenin. Ni J; Xie T; Xiao M; Xiang W; Wang L Biochem Biophys Res Commun; 2018 Sep; 503(2):956-962. PubMed ID: 29932919 [TBL] [Abstract][Full Text] [Related]
3. Morphine activates blast-phase chronic myeloid leukemia cells and alleviates the effects of tyrosine kinase inhibitors. Zhou Z; Liu T; Zhang J Biochem Biophys Res Commun; 2019 Dec; 520(3):560-565. PubMed ID: 31615652 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic anisomycin selectively targets leukemia cell lines and patient samples through suppressing Wnt/β-catenin signaling. Li Y; Hu J; Song H; Wu T Biochem Biophys Res Commun; 2018 Nov; 505(3):858-864. PubMed ID: 30301525 [TBL] [Abstract][Full Text] [Related]
5. Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia. Jin B; Wang C; Li J; Du X; Ding K; Pan J Clin Cancer Res; 2017 Feb; 23(3):789-803. PubMed ID: 27492973 [TBL] [Abstract][Full Text] [Related]
6. Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function. Xiao M; Ai H; Li T; Rajoria P; Shahu P; Li X Biochem Biophys Res Commun; 2016 Apr; 472(4):610-6. PubMed ID: 26966074 [TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E1 and Its Analog Misoprostol Inhibit Human CML Stem Cell Self-Renewal via EP4 Receptor Activation and Repression of AP-1. Li F; He B; Ma X; Yu S; Bhave RR; Lentz SR; Tan K; Guzman ML; Zhao C; Xue HH Cell Stem Cell; 2017 Sep; 21(3):359-373.e5. PubMed ID: 28844837 [TBL] [Abstract][Full Text] [Related]
8. Anthelmintic drug niclosamide enhances the sensitivity of chronic myeloid leukemia cells to dasatinib through inhibiting Erk/Mnk1/eIF4E pathway. Liu Z; Li Y; Lv C; Wang L; Song H Biochem Biophys Res Commun; 2016 Sep; 478(2):893-9. PubMed ID: 27520370 [TBL] [Abstract][Full Text] [Related]
9. Sevoflurane affects neurogenesis through cell cycle arrest via inhibiting wnt/β-catenin signaling pathway in mouse neural stem cells. Liu S; Fang F; Song R; Gao X; Jiang M; Cang J Life Sci; 2018 Sep; 209():34-42. PubMed ID: 30071197 [TBL] [Abstract][Full Text] [Related]
10. [Research Advance on Classic Wnt Pathway in Chronic Myelogenous Leukemia--Review]. Cao ZR; Chen XP; Hu J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):350-353. PubMed ID: 32027302 [TBL] [Abstract][Full Text] [Related]
11. Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI. Agarwal P; Zhang B; Ho Y; Cook A; Li L; Mikhail FM; Wang Y; McLaughlin ME; Bhatia R Blood; 2017 Feb; 129(8):1008-1020. PubMed ID: 28011678 [TBL] [Abstract][Full Text] [Related]
12. Propofol inhibits biological functions of leukaemia stem and differentiated cells through suppressing Wnt/β-catenin and Akt/mTOR. Chen L; Wan Y; Liu Y; Li T Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):127-134. PubMed ID: 31429973 [TBL] [Abstract][Full Text] [Related]
13. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL. Aljedai A; Buckle AM; Hiwarkar P; Syed F PLoS One; 2015; 10(4):e0123016. PubMed ID: 25849484 [TBL] [Abstract][Full Text] [Related]
14. Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls. de Cássia Viu Carrara R; Fontes AM; Abraham KJ; Orellana MD; Haddad SK; Palma PVB; Panepucci RA; Zago MA; Covas DT Clin Transl Oncol; 2018 Apr; 20(4):542-549. PubMed ID: 28905209 [TBL] [Abstract][Full Text] [Related]
16. Depletion of γ-catenin by Histone Deacetylase Inhibition Confers Elimination of CML Stem Cells in Combination with Imatinib. Jin Y; Yao Y; Chen L; Zhu X; Jin B; Shen Y; Li J; Du X; Lu Y; Jiang S; Pan J Theranostics; 2016; 6(11):1947-62. PubMed ID: 27570562 [TBL] [Abstract][Full Text] [Related]
17. Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia. Jin Y; Zhou J; Xu F; Jin B; Cui L; Wang Y; Du X; Li J; Li P; Ren R; Pan J J Clin Invest; 2016 Oct; 126(10):3961-3980. PubMed ID: 27643437 [TBL] [Abstract][Full Text] [Related]
18. Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists. Zhao Y; Wu K; Wu Y; Melendez E; Smbatyan G; Massiello D; Kahn M Curr Mol Pharmacol; 2018; 11(2):113-121. PubMed ID: 28933312 [TBL] [Abstract][Full Text] [Related]
19. Propofol enhances BCR-ABL TKIs' inhibitory effects in chronic myeloid leukemia through Akt/mTOR suppression. Tan Z; Peng A; Xu J; Ouyang M BMC Anesthesiol; 2017 Sep; 17(1):132. PubMed ID: 28962554 [TBL] [Abstract][Full Text] [Related]
20. Effects of imidazole derivatives on cellular proliferation and apoptosis in myeloid leukemia. Nadeem BB; Bibi A; Khan M; Sajjad GR; Adnan F; Ahmad Z; Khan D BMC Cancer; 2024 Sep; 24(1):1200. PubMed ID: 39342179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]